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Blacks	are	two	to	three	times	as	likely	as	whites	to	die	of	preventable	heart	disease	
and	stroke.	Declines	in	mortality	from	heart	disease	have	not	eliminated	racial	dispari-
ties.	Control	and	effective	treatment	of	hypertension,	a	leading	cause	of	cardiovascu-
lar	disease,	among	blacks	is	less	than	in	whites	and	remains	a	challenge.	One	of	the	
driving	forces	behind	this	racial/ethnic	disparity	 is	medication	nonadherence	whose	
cause	 is	embedded	 in	social	determinants.	Eight	practical	approaches	to	addressing	
medication	adherence	with	the	potential	to	attenuate	disparities	were	identified	and	
include:	(1)	patient	engagement	strategies,	(2)	consumer-	directed	health	care,	(3)	pa-
tient	portals,	(4)	smart	apps	and	text	messages,	(5)	digital	pillboxes,	(6)	pharmacist-	led	
engagement,	 (7)	 cardiac	 rehabilitation,	 and	 (8)	 cognitive-	based	 behavior.	 However,	
while	data	suggest	that	these	strategies	may	improve	medication	adherence,	the	ef-
fect	on	ameliorating	racial/ethnic	disparities	is	not	certain.	This	review	describes	the	
relationship	between	disparities	and	medication	adherence,	which	likely	plays	a	role	in	
persistent	disparities	in	cardiovascular	morbidity	and	mortality.
1  | INTRODUCTION
Along	with	disparities	 in	morbidity	and	mortality	of	cardiovascular	dis-
eases	 (CVDs),	persistent	differences	 in	adherence	 to	pharmacotherapy	
have	been	observed	among	racial/ethnic	subgroups	of	the	United	States.1
In	2011-2014,	the	prevalence	of	hypertension	among	black	(41.2%)	
adults	was	higher	than	among	non-	Hispanic	white	(28.0%),	non-	Hispanic	
Asian	(24.9%),	and	Hispanic	(25.9%)	adults	(Figure	1).	In	addition,	hyper-
tension	prevalence	among	blacks	was	among	the	highest	 in	 the	world	
despite	no	definitive	genetic	factors	with	blacks	having	higher	average	
blood	 pressures	 (BPs)	 compared	with	whites.2	 In	 the	 National	 Health	
and	Nutrition	Examination	Survey	(NHANES)	2011–2012,	hypertension	
awareness	and	treatment	rates	were	greater	but	control	rates	were	lower	
in	black	patients	compared	with	non-	Hispanic	whites	(85.7%	vs	82.7%	
for	awareness,	77.4%	vs	76.7%	for	treatment,	and	49.5%	vs	53.9%	for	
control,	respectively)	(Figure	2).3	According	to	the	most	recent	data,	the	
control	and	effective	treatment	of	hypertension	among	blacks	is	less	than	
in	whites	and	remains	a	challenge.4	A	potential	cause	of	this	 finding	 is	
based	on	evidence	from	six	studies	showing	a	positive	relationship	be-
tween	ambulatory	BP	(particularly	at	night)	and	reports	of	social	injustice,5 
attesting	to	the	multicomponent	nature	of	racial	healthcare	disparities.
Medication	 nonadherence	 is	 a	 leading	 cause	 of	 inadequate	 hy-
pertension	management	 leading	 to	CVD,	stroke,	and	chronic	kidney	
disease.1	Approximately	50%	of	patients	with	CVD	have	suboptimal	
adherence	to	their	prescribed	medications,	with	deleterious	effects	on	
morbidity,	mortality,	and	healthcare	costs.6,7
When	compared	with	white	patients,	blacks	are	disproportionately	
afflicted	 by	 poor	 adherence	 to	 cardiovascular	 medications,	 such	 as	
angiotensin-	converting	enzyme	inhibitors,	β-	blockers,	and	statins,8-12 
even	 in	environments	with	equitable	access	 to	prescription	drugs.13 
However,	despite	multiple	approaches	to	enhance	adherence,	there	is	
no	single	intervention	or	strategy	that	has	proven	effective	across	all	
patients	and	health	systems.14
A	 retrospective	 study	 evaluated	 hypertension	 registries	 in	 an	
inner-	city	healthcare	delivery	system	(N=17	176)	and	a	health	mainte-
nance	organization	(N=94	297)	to	develop	clinical	prediction	rules	for	
2  |     FERDINAND Et Al.
adherence	with	antihypertensive	medications.15	In	these	populations,	
only	 36%	of	 the	 total	 number	 of	 patients	were	 adherent.	Adherent	
patients	were	 likely	 to	be	older,	white,	married,	 and	 acculturated	 in	
US	 society;	 to	have	diabetes	mellitus	or	 cerebrovascular	disease;	 to	
not	 abuse	 alcohol	 or	 controlled	 substances;	 and	 to	 be	 prescribed	
fewer	 than	 three	 antihypertensive	 medications.	 Although	 sociode-
mographic	characteristics	or	clinical	diagnoses	were	statistically	asso-
ciated	with	adherence,	 the	combination	of	these	characteristics	was	
not	 sufficiently	 accurate	 to	 allow	clinicians	 to	predict	whether	 their	
patients	will	be	adherent	to	treatment.
Solomon	and	colleagues16	recently	demonstrated	a	strong	associ-
ation	between	medication-	taking	consistency,	medication	adherence,	
and	 BP	 control	 in	 black	 patients	 with	 hypertension	 representing	 a	
lower	socioeconomic	cohort.	Younger	black	patients	were	more	likely	
to	have	variable	medication-	taking	routines	and	thus	lower	adherence	
to	treatment	compared	with	older	black	patients.	Notably,	the	findings	
F IGURE  1 Prevalence	of	hypertension	among	adults	aged	18	and	over,	by	sex	and	race	and	Hispanic	origin:	United	States,	2011-2014.	
1Significant	difference	from	non-	Hispanic	Asian.	2Significant	difference	from	non-	Hispanic	white.	3Significant	difference	from	Hispanic.	
4Significant	difference	from	women	in	same	race	and	Hispanic	origin	group.	Note:	Estimates	are	age-	adjusted	by	the	direct	method	to	the	2000	
U.S.	census	population	using	age	groups	18-	39,	40-	59,	and	over;	see	reference	9.	Source:	Centers	for	Disease	Control	and	Prevention/National	
Center	for	Health	Statistics,	National	Health	and	Nutrition	Examination	Survey,	2011-2014.	https://www.cdc.gov/nchs/data/databriefs/db220.
pdf
F IGURE  2 Prevalence	of	controlled	hypertension	among	adults	with	hypertension	aged	18	and	over,	by	sex	and	race	and	Hispanic	origin:	
United	States,	2011-2014.	1Significant	difference	from	non-	Hispanic	Asian.	2Significant	difference	from	non-	Hispanic	black.	3Significant	
difference	from	Hispanic.	4Significant	difference	from	women	in	same	race	and	Hispanic	origin	group.	 
Note:	Estimates	are	age-	adjusted	by	the	direct	method	using	computed	weights	based	on	the	subpopulation	of	persons	with	hypertension	in	the	
2001-	2012	National	Health	and	Nutrition	Examination	Survey;	see	reference	7.	Source:	Centers	for	Disease	Control	and	Prevention/National	
Center	for	Health	Statistics,	National	Health	and	Nutrition	Examination	Survey,	2011-2014.	https://www.cdc.gov/nchs/data/databriefs/db220.pdf
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also	demonstrated	that	most	sociodemographic	characteristics	were	
not	associated	with	adherence	and	better	BP	control,	thus	attesting	to	
the	multifactorial	nature	of	BP	control.
While	medication	nonadherence	is	a	major	patient-	related	factor	
in	 inadequate	BP	control	 in	 all	 populations,	 there	 are	 several	phy-
sician	 or	 provider	 factors	 that	may	 significantly	 undermine	 hyper-
tension	treatment,	including	therapeutic	inertia	and	confusion	over	
the	many	medications	and	combination	therapies	available	for	use.17 
More	time	should	be	spent	strategizing	with	patients	about	adher-
ence	 issues,	 emphasizing	 the	 importance	 of	 maintaining	 routines,	
discussing	belief	systems	and	barriers	that	stand	between	patients	
and	 effective	 BP	 control.	 Team-	based	 care	 involving	 nonphysician	
providers	 along	 with	 innovative	 strategies	 appear	 to	 assist	 with	
adherence.18
Over	recent	decades,	dramatic	improvements	in	US	CVD	mortal-
ity,	life	expectancy,	and	overall	health	care	have	not	occurred	equally	
across	race/ethnic	groups.	At	 least	200	000	deaths	from	heart	dis-
ease	 and	 stroke	 each	 year	 are	 preventable,	 and	 blacks	 are	 nearly	
twice	 as	 likely	 as	 whites	 to	 die	 of	 preventable	 heart	 disease	 and	
stroke.19	The	2013-2014	life	expectancy	was	consistently	lowest	in	
non-	Hispanic	blacks	at	birth	and	at	age	65	years,	primarily	driven	by	
higher	hypertension	and	CVD	mortality	 (Figure	3).	 In	consideration	
of	 these	unacceptable	 gaps	 in	morbidity	 and	mortality,	 absent	 sig-
nificant	biologic	explanation,	it	is	beneficial	to	focus	on	the	potential	
critical	 contribution	 of	 nonadherence,	mediated	 by	 social	 determi-
nants,	as	an	underlying	contributor	to	suboptimal	BP	and	CVD	risks	
control.
Although	health	disparities	in	the	United	States	are	not	limited	to	
race,	racial/ethnic	disparities	are	well	documented	and	persistent,	with	
evidence	of	earlier	onset	and	greater	severity	of	disease	at	various	lev-
els	of	socioeconomic	status.20	These	differences	may	be	noted	even	
after	controlling	for	health	insurance,	socioeconomic	status,	stage	and	
severity	of	disease,	comorbidity,	and	the	type	of	medical	facility.21	This	
review	examines	persistent	racial	disparities	and	the	impactful	role	of	
medication	 adherence	 in	 support	 of	 a	 critical	 public	 health	mission:	
decreasing	 CVD	 among	 subpopulations	 and	 high-	quality	 monitor-
ing	 of	 population	BP	 levels	 and	 hypertension	 prevalence,	 diagnosis,	
treatment,	and	control	pursuant	to	the	Scientific	Statement	from	the	
American	Heart	Association	on	the	Social	Determinants	of	Risk	and	
Outcomes	for	Cardiovascular	Disease.5,22
2  | METHODOLOGY
We	systematically	searched	PubMed,	ERIC,	and	the	Cochrane	Database	
of	Systematic	Reviews	for	English-	language	articles	published	in	peer-	
reviewed	 journals	 between	 2014	 and	 2016,	 using	 the	 search	 terms	
medication	adherence	and	racial	disparity	in	blacks.	Our	search	was	fo-
cused	on	recent	literature	to	emphasize	the	current	status	of	the	dispar-
ity	issues.	We	then	cross-	searched	the	reference	lists	of	these	studies	to	
identify	additional	older	studies	that	were	used	in	our	review	if	consid-
ered	significant	and	contributory	to	our	evaluation	of	the	current	state.
3  | RESULTS
Our	 review	 identified	social	determinants	 (ie,	patient-	provider	com-
munication	and	socioeconomic	status)	as	key	parameters	that	affect	
adherence	and	disparity	(Table	1)	and	eight	practical	approaches	ad-
dressing	medication	adherence	with	the	potential	to	attenuate	dispar-
ities	 (Table	2):	 (1)	patient	engagement,	 (2)	consumer-	directed	health	
care,	(3)	patient	portals,	(4)	smart	apps	and	text	messages,	(5)	digital	
pillboxes	and	pill	bottles,	 (6)	pharmacist-	led	engagement,	 (7)	cardiac	
rehabilitation,	and	(8)	cognitive-	based	behavior.
F IGURE  3 Life	expectancy	at	birth,	by	race	and	origin:	US,	2013	and	2014.	Note:	Life	expectancies	are	based	on	death	rates	that	have	
been	adjusted	for	race	and	Hispanic	origin	misclassification	on	death	certificates	(reference	1	in	report).	Arias	E.	United	States	life	tables,	2011.	
National	vital	statistics	reports;	vol	64,	no	11.	Hyattsville,	MD:	National	Center	for	Health	Statistics;	2015.	Source:	Centers	for	Disease	Control	
and	Prevention/National	Center	for	Health	Statistics,	National	Vital	Statistics	System,	Mortality	Public	domain.	No	permission	needed.	Access	
data	table	for	Figure	1	at:	http://www.cdc.gov/nchs/data/databriefs/db244.pdf
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3.1 | Social determinants of disparities  
and nonadherence
3.1.1 | Patient- provider communication
Although	unscientific	health	beliefs	are	common,	 structured	patient	
belief	 assessments	may	 assist	with	 identifying	 discordant	 beliefs.	 A	
systematic	review	of	22	studies,	including	6516	participants,	demon-
strated	that	the	perception	by	blacks	that	hypertension	was	episodic	
and	 symptomatic	 led	 to	 infrequent	medication	use.23	Reconciliation	
of	differences	between	patient-	provider	understanding	as	well	as	cul-
tural	differences,	may	improve	adherence	and	acceptance	of	medical	
treatments	among	black	patients	with	hypertension.23
Between	 2002	 and	 2013,	 person-	centered	 care	 disparities	 in	
patients	who	 reported	poor	 communication	with	healthcare	provid-
ers	 persisted	 and	were	 driven	 by	 race	 and	 financial	 income	despite	
an	overall	trend	in	improvement	(Figure	4).	The	percentage	of	adults	
who	 reported	 substandard	 communication	 with	 health	 providers	
significantly	decreased	 for	whites,	Hispanics,	and	all	 income	groups.	
However,	there	were	no	statistically	significant	changes	among	blacks	
for	the	same	time	period.
3.1.2 | Socioeconomic status
Socioeconomic	 status	 has	 a	 profound	 impact	 on	 CVD	 morbid-
ity,	mortality,	 and	medication	 adherence.	Among	 the	 7.8%	of	US	
adults	 who	 did	 not	 take	 their	 medication	 as	 prescribed	 to	 save	
money,	 the	poorest	adults	were	most	 likely	 to	be	nonadherent.24 
The	 geographic	 distribution	 of	 preventable	 death	 from	 CVD	 and	
stroke	was	skewed	with	significantly	higher	death	in	southeastern	
states	 (Figure	5).	 The	 higher	 preventable	mortality	 in	 these	 areas	
was	driven	primarily	by	adverse	social	determinants	of	health	and	
TABLE  1 Findings	on	social	determinants	affecting	medication	adherence	and	disparity
First author 
(Year)
Social 
determinants Key finding Conclusion Reference
Buckley	
(2016)
Patient-	provider	
communication
Black	health	beliefs	concerning	hypertension	
may	differ	from	those	of	healthcare	
providers	and	other	ethnicities
Reconciliation	of	differences	between	patient	
and	provider	expectations	for	disease	
management	may	improve	adherence	to	
medical	treatments	among	black	patients	
with	hypertension
23
Cohen	(2015) Socioeconomic	
status
In	order	to	save	money,	almost	8%	of	US	
adults	aged	18	and	older	did	not	take	
medication	as	prescribed
Belief	that	the	recommended	pharmacother-
apy	is	needed	and	an	understanding	of	the	
recommended	treatment	have	been	found	
to	be	lower	among	older	adults	who	are	
economically	vulnerable,	compared	with	
those	with	higher	income
24
Mulcahy 
(2016)
Uninsured	people	who	gained	private	
coverage	filled,	on	average,	28%	more	
prescriptions	and	had	29%	less	out-	of-	
pocket	spending	per	prescription	in	2014	
compared	with	2013
By	reducing	financial	barriers	to	care,	the	
Affordable	Care	Act	has	increased	treatment	
rates	while	reducing	out-	of-	pocket	spending,	
particularly	for	people	with	chronic	
conditions
25
Rolnick	(2013) Overall,	adherence	rates	were	higher	for	
those	living	in	higher	socioeconomic	areas	
and	for	whites.	Those	in	the	lowest	quartile	
of	the	living	area	variables	(education,	
poverty,	income)	had	lower	drug	adherence	
than	those	in	other	quartiles
There	are	variable	adherence	rates	by	
condition,	and,	in	a	population	with	
prescription	coverage	offering	multiple	
avenues	with	which	to	obtain	medications,	
the	findings	pointed	to	the	need	to	consider	
additional	efforts	to	boost	adherence	rates
26
Hussein	
(2015)
Part	D	introduction	was	associated	with	a	
16-	percentage-	point	decrease	in	the	
white–Hispanic	disparity	in	achieving	80%	
adherence	to	cardiovascular	medications,	
but	with	no	significant	net	change	in	
white–black	disparities
Proactively	taking	the	needs	of	vulnerable	
populations	into	account	when	designing	
policies,	such	as	Part	D,	is	paramount	to	
prevent	unintended	disparity	consequences
27
Ferdinand	
(2017)
Socioeconomic	factors	that	adversely	affect	
adherence	include	poverty,	illiteracy,	
unemployment,	lack	of	social	support	
networks,	unstable	living	conditions,	
greater	distance	from	treatment	centers,	
higher	out-	of-	pocket	cost	of	medications	
and	care,	lack	of	transportation,	cultural	
beliefs	reflecting	mistrust	in	the	healthcare	
system,	and	family	dysfunction
Efforts	to	alter	nonadherence	on	an	individual	
or	a	population	level	must	take	into	account	
community	dynamics	that	affect	the	
environment	in	which	individuals	make	
decisions	about	adherence
28
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correlated	with	Centers	for	Disease	Control	and	Prevention	socio-
environmental	 maps	 of	 poverty,	 unemployment,	 education,	 and	
lack	of	health	insurance.
The	Affordable	Care	Act	has	expanded	US	health	insurance	cover-
age,	with	as	much	as	a	30%	reduction	in	the	proportion	of	this	popu-
lation	that	was	uninsured	in	2014	compared	with	2013.	Furthermore,	
uninsured	 people	 who	 gained	 private	 coverage	 filled,	 on	 average,	
28%	 more	 prescriptions	 and	 had	 29%	 less	 out-	of-	pocket	 spending	
per	prescription.25	Therefore,	for	chronic	conditions,	access	to	health	
insurance	appeared	to	reduce	financial	barriers	to	care	and	 increase	
treatment	 rates.	 Overall,	 medication	 adherence	was	 higher	 in	 men,	
whites,	older	patients,	and	those	living	in	areas	with	higher	education	
rates	and	higher	income.26
The	Medicare	Part	D	program	offers	a	generous	 federal	 subsidy	
to	 individuals	 below	 150%	 of	 the	 federal	 poverty	 line.	 Overall,	 the	
introduction	of	Part	D	was	associated	with	a	16%-	percentage-	point	
decrease	in	the	white–Hispanic	disparity	in	achieving	80%	adherence	
to	cardiovascular	medications,	but	with	no	significant	net	change	 in	
white–black	disparities.	Among	seniors,	however,	average	adherence	
actually	worsened	11	percentage	points	(P<.001)	more	among	blacks	
relative	to	their	white	counterparts.27	The	likely	reason	for	these	find-
ings	 is	the	multifactorial	nature	of	medication	adherence	and	its	 im-
pact	on	racial	disparity.28
4  | PRACTICAL APPROACHES TO 
ADDRESS MEDICATION ADHERENCE 
WITH THE POTENTIAL TO ADDRESS 
RACIAL DISPARITIES
4.1 | Patient engagement to address disparities and 
nonadherence
Adherence	 improves	 when	 providers	 engage	 patients	 in	 their	
health	 care,	 and	 patients	 are	 better	 educated,	 informed,	 and	 in-
teractive	 in	 making	 healthcare	 decisions	 best	 suited	 to	 them.29 
However,		patient	engagement	may	be	a	more	difficult	goal	among	
minorities.30
In	 the	 modern	 era	 of	 transparent,	 patient-	centered	 medicine	
and	 shared	 decision	 making,	 indications-	based	 prescribing	 has	
multiple	potential	benefits,	including,	but	not	limited	to,	improving	
medication	safety	and	enhanced	healthcare	team	communication.31 
Patients	 who	 have	 optimal	 knowledge	 about	 their	 medications	
demonstrate	 better	 adherence	 and	 fewer	 errors.32 To enhance 
knowledge,	 the	 US	 Food	 and	 Drug	 Administration’s	 efforts	 are	
	focused	on	ways	in	which	regulatory	strategies,	labeling,	and	patient	
information	 can	 interdigitate	 with	 healthcare	 delivery	 to	 improve	
medication	adherence.28
4.2 | Consumer- directed health care: an 
emerging concept
Consumer-	directed	 health	 care	 promotes	 cost	 sharing	 and	 encour-
ages	consumers	to	be	engaged	in	their	care,	becoming	more	informed	
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and	 making	 smarter	 decisions	 when	 accessing	 healthcare	 services.	
Insurers	or	employers	make	available	evidence-	based	drugs	 at	 little	
or	no	cost.	In	a	retrospective	observational	study	of	employees	from	
a	 large	global	pharmaceutical	 firm,	prescription	medication	use	 rose	
5%	per	enrollee	across	the	entire	enrolled	population	and	increased	
use	was	most	evident	for	patients	taking	cardiovascular	medication.	
Although	not	detailed	by	race/ethnicity,	importantly,	by	the	third	year,	
cardiovascular	 medication	 adherence	 was	 9.4%	 higher.33	 Based	 on	
findings	 from	 social-	determinant	 evaluation,	 it	 is	 uncertain	whether	
this	emerging	concept	will	ameliorate	disparities.
F IGURE  4 Disparities	in	person-	
centered	care.	Panel	(A)	depicts	racial	
differences	in	patients	reporting	poor	
communications	with	health	provider,	over	
a	period	of	10	years	from	2002–2012.	
Panel	(B)	depicts	differences	in	Hispanic	
patients	reporting	poor	communications	
with	health	provider,	based	on	income	over	
a	period	of	10	years	from	2002–2012.	
Source:	Agency	for	Healthcare	Research	
and	Quality,	Medical	Expenditure	panel	
survey,	2002–2012
(A) (B)
F IGURE  5 National	Vital	Statistics	System,	US	Census	Bureau,	2008–2010.	View	more	maps	at	the	Interactive	Atlas	for	Heart	Disease	and	
Stroke:	http://nccd.cdc.gov/DHDSPAtlas/
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4.3 | Patient portals and electronic health records
Increasingly,	 electronic	 health	 records	 feature	 patient	 portals	 that	
allow	 patients,	 among	 many	 other	 options,	 to	 request	 prescription	
refills,	 saving	 time	 and	 money.34	 Overall,	 limited	 access	 to	 a	 per-
sonal	computer	or	means	to	connect	with	the	internet	for	utilization	
of	 health	 care	was	 twice	 for	 blacks	 (46%)	 than	 for	whites	 (21%).34 
Contemporary	data	also	show	significant	racial	variability	in	utilization	
of	patient	portals.	Patient	portals	and	electronic	records	are	unlikely	
to	reduce	disparities	if	access	to	computers	and	patient	education	are	
not	integrated	into	this	strategy.
4.4 | Smartphone apps and text messages
For	many	patients,	routine	text	messaging	may	be	considered	to	en-
hance	adherence.	 In	a	meta-	analysis	of	 randomized	controlled	 trials	
published	 between	 2005	 and	 2008,	 eight	 of	 nine	 interventions	 for	
disease	 prevention	 and	management	 showed	 a	 positive	 short-	term	
effect	utilizing	some	form	of	automated	reminders.	Clearly,	text	mes-
saging	and	mobile	health	technologies	represent	a	unique	opportunity	
to	 enhance	medication	 adherence	 and	 healthcare	 outcomes.	 A	 key	
criterion	 for	any	adherence-	enhancing	 intervention	 is	 that	 it	 should	
be	tailored	to	address	the	root	causes	of	nonadherence.
Mobile	technology	and	associated	health	apps	have	gained	pop-
ularity	with	a	growing	market	in	recent	years.	In	a	contemporary	sys-
tematic	 review,	 digital	 health	 interventions,	 including	 mobile	 apps	
were	 significantly	 associated	 with	 improved	 CVD	 outcomes.35 The 
main	 challenges	 to	 increase	 adherence	 and	 reduce	 disparities	 with	
these	novel	tools	are	ease	of	use,	costs,	and	adoption	by	blacks	and	
persons	with	 low	 socioeconomic	 status.	Text	messaging	 appears	 to	
improve	adherence	and	potential	outcomes	in	all	patient	populations	
and,	in	a	contemporary	pooled	analysis,	it	increased	medication	adher-
ence	rates	from	50%	to	67.8%.36
4.5 | Digital pillboxes and pill bottles
Digital	pillboxes	and	pill	bottles	have	already	been	shown	to	improve	
medication	adherence	by	engaging	patients	in	innovative	ways.	For	in-
stance,	a	wireless	electronic	pill	bottle,	which	reminded	patients	with	
hypertension	 to	 take	 their	medication	 by	 emitting	 light	 and	 sound,	
increased	medication	 adherence	 by	 27%,	 over	 the	 control	 group.37 
There	are	no	data	on	racial	disparities.
4.6 | Pharmacist- led engagement
Increasingly,	pharmacist-	led	engagement	has	been	shown	to	enhance	
patient	 adherence.	 Physician-	pharmacist	 collaboration	 improves	 BP	
including	 patients	 with	 low	 incomes,	 those	 receiving	 Medicaid,	 or	
those	without	insurance.	In	a	recent	trial	involving	32	medical	offices	
in	15	states,	a	clinical	pharmacist	was	embedded	within	each	office	
and	made	 recommendations	 to	physicians	and	patients	 in	 interven-
tion	offices.38	BP	was	lower	at	9	months	in	both	the	control	and	in-
tervention	group	in	all	sociodemographic	categories	when	compared	
with	baseline.	Over	half	of	the	patients	were	minorities	(54.7%),	with	
the	majority	of	those	being	black	(71%)	and	Hispanic	(26%).	Notably,	
there	were	trends	for	minority	patients	who	received	the	intervention	
to	have	 a	 lower	BP	 than	nonminority	 patients	 in	 the	 control	 group	
(3.8	mm	Hg;	95%	confidence	interval,	−7.9	to	0.4	[P=.5846]).	In	addi-
tion,	there	was	a	significantly	greater	reduction	in	systolic	BP	in	the	in-
tervention	group	of	patients	making	<$25	000	than	the	control	group	
of	patients	making	<$25	000	 (7.3	mm	Hg;	95%	confidence	 interval,	
2.0–12.6	[P=.008]).	Thus,	pharmacist	intervention	reduced	racial	and	
socioeconomic	disparities	in	the	treatment	of	BP.
4.7 | Cardiac rehabilitation
Patient	engagement	via	cardiac	rehabilitation	improves	outcomes,	in-
cluding	mortality,	and	is	associated	with	improved	medication	adher-
ence	in	patients	post	myocardial	infarction.39	In	an	analysis	of	patients	
with	Medicare	Part	D,	the	number	of	cardiac	rehabilitation	sessions	
attended	was	positively	associated	with	improved	medication	adher-
ence	and	lower	cardiovascular	risk	over	time.39	Multiple	studies	have	
documented	underutilization	of	 cardiac	 rehabilitation	 in	 the	general	
population	and	have	also	identified	race	as	a	significant	factor	contrib-
uting	to	underutilization.40
4.8 | Cognitive- based behavior
A	promising	 approach	 is	 the	 use	 of	 cognitive-	based	 behavior	 strat-
egies	such	as	motivational	 interviewing.41	Motivational	 interviewing	
is	direct,	patient-	centered	counseling	designed	to	stimulate	patients	
for	 change	 by	 helping	 them	 recognize	 and	 resolve	 the	 discrepancy	
	between	their	behavior,	personal	goals,	and	values.
5  | SUMMARY 
Disparities	in	US	health	care	availability,	utilization,	and	outcomes	re-
lated	to	race/ethnicity	are	persistent	and	unacceptable	and	an	ongo-
ing	concern	tied	to	economic	status	and	communication	deficiencies	
between	the	healthcare	team	and	the	patient.	To	date,	adherence	in-
terventions	have	had	limited	impact,	perhaps	partly	because	of	their	
one-	size-	fits-	all	model.	Therefore,	we	recommend	eight	different	ap-
proaches	to	address	the	multidimensional	scope	of	medical	adherence.	
Enhancing	adherence	is	potentially	an	effective	and	efficient	means	of	
improving	US	health	outcomes	and	addressing	health	disparities.
These	approaches	include	patient	engagement,	consumer-	directed	
health	 care,	 patient	 portals,	 smartphone	 apps,	 digital	 pillboxes	 and	
pill	 bottles,	 pharmacist-	led	 engagement,	 cardiac	 rehabilitation,	 and	
cognitive-	based	behavior.	All	of	the	aforementioned	new	and	emerg-
ing	strategies	and	technologies	must	also	be	designed	to	ensure	cul-
tural	 acceptability,	 accessibility,	 and	clinical	 effectiveness	across	 the	
diverse	 populations	 served.	The	 current	 data	 suggest	 that	 although	
these	strategies	may	improve	adherence	and	reduce	racial/ethnic	and	
socioeconomic	disparities,	 the	overall	effect	on	 racial/ethnic	health-
care	disparities	is	unknown.
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6  | CONCLUSIONS
Racial,	ethnic,	and	social	determinants	of	health	disparities	in	health-
care	outcomes	require	special	attention	toward	improving	population-	
based	national	health	status.	In	parallel,	efforts	to	improve	adherence	
must	 also	 consider	 cultural	 preferences	 and	 differences.	 More	 fo-
cused	research	and	better	means	to	monitor	and	improve	adherence	
are	essential.
DISCLAIMER
The	 opinions	 and	 content	 of	 this	 article	 do	 not	 necessarily	 reflect	
guidance	or	policies	of	the	US	Food	and	Drug	Administration.
AUTHORSHIP
All	authors	actively	contributed	to	the	conception,	writing,	and	editing	
of	this	article	with	no	outside	writing	assistance.
CONFLICT OF INTEREST
Dr	Cryer	serves	as	consultant	for	Esperion	Therapeutics.	Dr	Ferdinand	
received	 a	 grant	 from	Boehringer	 Ingleheim	 and	 serves	 as	 consult-
ant	 for	 Amgen,	 Sanofi,	 Boehringer	 Ingleheim,	 Quantum	 Genomics,	
Novartis,	and	Eli	Lily.	Drs	Senatore,	Clayton-	Jeter,	Lewin,	Nasser,	and	
Yadav	have	nothing	to	disclose.
REFERENCES
	 1.	 Ritchey	M,	Chang	A,	Powers	C,	et	al.	Vital	signs:	disparities	 in	anti-
hypertensive	 medication	 nonadherence	 among	 Medicare	 part	 D	
beneficiaries—United	 States,	 2014.	 MMWR Morb Mortal Wkly Rep. 
2016;65:967-976.
	 2.	 Flack	JM,	Sica	DA,	Bakris	G,	et	al.	International	Society	on	Hypertension	
in	Blacks.	Management	of	high	blood	pressure	in	blacks:	an	update	of	
the	International	Society	on	Hypertension	in	Blacks	consensus	state-
ment.	Hypertension. 2010;56:780-800.
	 3.	 Whelton	 PK,	 Einhorn	 PT,	Muntner	 P,	 et	 al.	 Research	 needs	 to	 im-
prove	 hypertension	 treatment	 and	 control	 in	 African	 Americans.	
Hypertension. 2016;68:1066-1072.
	 4.	 Yoon	 SS,	Carroll	MD,	 Fryar	CD.	Hypertension	 prevalence	 and	 con-
trol	 among	 adults:	 United	 States,	 2011–2014.	 NCHS Data Brief. 
2015;(220):1-8.
	 5.	 Havranek	 EP,	 Mujahid	 MS,	 Barr	 DA,	 et	 al.	 Social	 determinants	
of	 risk	 and	 outcomes	 for	 cardiovascular	 disease.	 Circulation. 
2015;132:873-898.
	 6.	 Kronish	 I,	 Ye	 S.	 Adherence	 to	 cardiovascular	 medication:	 lessons	
learned	and	future	direction.	Prog Cardiovasc Dis. 2013;55:590-600.
	 7.	 Crowley	 MJ,	 Zullig	 LL,	 Shah	 BR,	 et	 al.	 Medication	 non-	adherence	
after	myocardial	infarction:	an	exploration	of	modifying	factors.	J Gen 
Intern Med. 2015;30:83-90.
	 8.	 Lauffenburger	JC,	Robinson	JG,	Oramasionwu	C,	Fang	G.	Racial/eth-
nic	and	gender	gaps	in	the	use	of	and	adherence	to	evidence-	based	
preventive	 therapies	 among	 elderly	 Medicare	 part	 D	 beneficiaries	
after	acute	myocardial	infarction.	Circulation. 2014;129:754-763.
	 9.	 Lewey	J,	Shrank	WH,	Bowry	ADK,	Kilabuk	E,	Brennan	TA,	Choudhry	
NK.	Gender	 and	 racial	 disparities	 in	 adherence	 to	 statin	 therapy:	 a	
meta-	analysis.	Am Heart J. 2013;165:665-678.
	10.	 Zhang	Y,	Baik	S.	Race/ethnicity,	disability,	and	medication	adherence	
among	Medicare	 beneficiaries	with	 heart	 failure.	 J Gen Intern Med. 
2014;29:602-607.
	11.	 Zhang	Y,	Baik	SH,	Chang	C-CH,	Kaplan	CM,	Lave	JR.	Disability,	race/
ethnicity,	and	medication	adherence	among	Medicare	myocardial	in-
farction	survivors.	Am Heart J 2012;164:425-433.
	12.	 Holmes	 HM,	 Luo	 R,	 Hanlon	 JT,	 Elting	 LS,	 Suarez-Almazor	 M,	
Goodwin	 JS.	 Ethnic	 disparities	 in	 adherence	 to	 antihypertensive	
medications	 of	 Medicare	 Part	 D	 beneficiaries.	 J Am Geriatr Soc. 
2012;60:1298-1303.
	13.	 Saha	S,	Freeman	M,	Toure	J,	Tippens	KM,	Weeks	C,	Ibrahim	S.	Racial	
and	ethnic	disparities	in	the	VA	health	care	system:	a	systematic	re-
view. J Gen Intern Med. 2008;23:654-671.
	14.	 Bansilal	S,	Castellano	J,	Garrido	E,	et	al.	Assessing	the	impact	of	med-
ication	adherence	on	 long-	term	cardiovascular	outcomes.	 J Am Coll 
Cardiol. 2016;68:789-801.
	15.	 Steiner	JF,	Ho	PM,	Beaty	BL,	Dickinson	LM,	Hanratty	R,	Zeng	C,	et	al.	
Sociodemographic	 and	clinical	 characteristics	 are	not	 clinically	use-
ful	predictors	of	 refill	adherence	 in	patients	with	hypertension.	Circ 
Cardiovasc Qual Outcomes. 2009;2:451-457.
	16.	 Solomon	A,	 Seixas	A,	 Ogedegbe	 G,	 et	 al.	Medication	 routines	 and	
adherence	among	hypertensive	African	Americans.	J Clin Hypertens. 
2015;17:688-672.
	17.	 Anderson	TJ,	 Grégoire	 J,	 Pearson	GJ,	 et	 al.	 2016	Canadian	 cardio-
vascular	 society	 guidelines	 for	 the	management	of	dyslipidemia	 for	
the	prevention	of	cardiovascular	disease	 in	 the	adult.	Can J Cardiol. 
2016;32:1263-1282.
	18.	 Proia	KK,	Thota	AB,	Njie	GJ,	 et	 al.	Team-	based	 care	 and	 improved	
blood	pressure	control:	a	community	guide	systematic	review.	Am J 
Prev Med. 2014;47:86-99.
	19.	 Centers	 for	Disease	Control.	Racial/ethnic	disparities	 in	 the	aware-
ness,	 treatment,	 and	 control	 of	 hypertension-	United	 States,	 2003-	
2010. MMWR Morb Mortal Wkly Rep. 2013;62:351-355.
	20.	 Williams	DR,	Mohammed	SA,	Leavell	J,	Collins	C.	Race,	socioeconomic	
status	and	health:	complexities,	ongoing	challenges	and		research	op-
portunities.	Ann N Y Acad Sci. 2010;1186:69-101.
	21.	 Smedley	BD,	Stith	AY,	Nelson	AR,	eds.	Unequal Treatment: Confronting 
Racial and Ethnic Disparities in Health Care.	Washington,	DC:	Institute	
of	Medicine;	2002.
	22.	 Mueller	M,	Purnell	TS,	Mensah	GA,	Cooper	LA.	Reducing	racial	and	
ethnic	disparities	 in	hypertension	prevention	and	control:	what	will	
it	take	to	translate	research	into	practice	and	policy?	Am J Hypertens. 
2015;28:699-716.
	23.	 Buckley	L,	Labonville	S,	Barr	J.	A	systematic	review	of	beliefs	about	
hypertension	 and	 its	 treatment	 among	 African	 Americans.	 Curr 
Hypertens Rep. 2016;18:52.
	24.	 Cohen	RA,	Villarroel	MA.	 Strategies	used	by	 adults	 to	 reduce	 their	
prescription	 drug	 costs:	 United	 States,	 2013.	 NCHS Data Brief. 
2015;(184):1-8.
	25.	 Mulcahy	 AW,	 Eibner	 C,	 Finegold	 K.	 Gaining	 coverage	 through	
Medicaid	or	private	insurance	increased	prescription	use	and	lowered	
out-	of-	pocket	spending.	Health Aff. 2016;35:1725-1733.
	26.	 Rolnick	SJ,	Pawloski	PA,	Hedblom	BD,	Asche	SE,	Bruzek	RJ.	Patient	
characteristics	associated	with	medication	adherence.	Clin Med Res. 
2013;11:54-65.
	27.	 Hussein	M,	Waters	TM,	 Chang	 CF,	 Bailey	 JE,	 Brown	 LM,	 Solomon	
DK.	 Impact	 of	 Medicare	 part	 D	 on	 racial	 disparities	 in	 adherence	
to	cardiovascular	medications	among	the	elderly.	Med Care Res Rev. 
2016;73:410-436.
	28.	 Ferdinand	KC,	Senatore	FF,	Clayton-Jeter	H,	et	al.	Improving	medica-
tion	 adherence	 in	 cardiometabolic	 disease:	 practical	 and	 regulatory	
implications.	J Am Coll Cardiol. 2017;69:437-451.
	29.	 Scott	AB,	McClure	JE.	 Engaging	 providers	 in	medication	 adher-
ence:	a	health	plan	case	study.	Am Health Drug Benefits. 2010;3: 
372-380.
10  |     FERDINAND Et Al.
	30.	 Barello	S,	Graffigna	G.	Patient	engagement	 in	healthcare:	pathways	
for	 effective	 medical	 decision	 making.	 Neuropsychological Trends. 
2015;17:53-65.
	31.	 Schiff	GD,	Seoane-Vazquez	E,	Wright	A.	Incorporating	indications	into	
medication	ordering–time	to	enter	the	age	of	reason.	N Engl J Med. 
2016;375:306-309.
	32.	 Kuntz	 JL,	 Safford	 MM,	 Singh	 JA,	 et	 al.	 Patient-	centered	 inter-
ventions	 to	 improve	 medication	 management	 and	 adherence:	
a	 qualitative	 review	 of	 research	 findings.	 Patient Educ Couns. 
2014;97:310-326.
	33.	 Gibson	TB,	Wang	S,	Kelly	E,	et	al.	A	value-	based	insurance	design	pro-
gram	at	a	large	company	boosted	medication	adherence	for	employ-
ees	with	chronic	illnesses.	Health Aff. 2011;30:109-117.
	34.	 Graetz	 I,	Gordon	N,	Fung	V,	Hamity	C,	Reed	ME.	The	digital	divide	
and	patient	portals:	 internet	access	explained	differences	 in	patient	
portal	use	for	secure	messaging	by	age,	race,	and	income.	Med Care. 
2016;54:772-779.
	35.	 Widmer	 RJ,	 Collins	 NM,	 Collins	 CS,	West	 CP,	 Lerman	 LO,	 Lerman	
A.	 Digital	 health	 interventions	 for	 the	 prevention	 of	 cardiovascu-
lar	 disease:	 a	 systematic	 review	 and	meta-	analysis.	Mayo Clin Proc. 
2014;90:469-480.
	36.	 Thakkar	J,	Kurup	R,	Laba	T,	et	al.	Mobile	 telephone	text	messaging	
for	medication	adherence	in	chronic	disease:	a	meta-	analysis.	JAMA 
Intern Med. 2016;176:340-349.
	37.	 Inoue	 S,	Kodjebacheva	G,	 Scherrer	T,	 et	 al.	Adherence	 to	 hydroxy-
urea	 medication	 by	 children	 with	 sickle	 cell	 disease	 (SCD)	 using	
an	 electronic	 device:	 a	 feasibility	 study.	 Int J Hematol. 2016;104: 
200-207.
	38.	 Anderegg	MD,	Gums	TH,	Uribe	L,	Coffey	CS,	James	PA,	Carter	BL.	
Physician-	pharmacist	 collaborative	management:	 narrowing	 the	 so-
cioeconomic	blood	pressure	gap.	Hypertension. 2016;68:1314-1320.
	39.	 Doll	JA,	Hellkamp	A,	Thomas	L,	et	al.	Effectiveness	of	cardiac	reha-
bilitation	among	older	patients	after	acute	myocardial	infarction.	Am 
Heart J. 2015;170:855-864.
	40.	 Brady	S,	Purdham	D,	Oh	P,	Grace	S.	Clinical	and	sociodemographic	
correlates	of	referral	for	cardiac	rehabilitation	following	cardiac	revas-
cularization	in	Ontario.	Heart Lung. 2013;42:320-325.
	41.	 Lundahl	 B,	 Moleni	 T,	 Burke	 BL,	 et	 al.	 Motivational	 interviewing	 in	
medical	care	settings:	a	systematic	review	and	meta-	analysis	of	ran-
domized	controlled	trials.	Patient Educ Couns. 2013;93:157-168.
How to cite this article:	Ferdinand	KC,	Yadav	K,	Nasser	SA,	
et	al.	Disparities	in	hypertension	and	cardiovascular	disease	in	
blacks:	The	critical	role	of	medication	adherence.	J Clin 
Hypertens. 2017;00:1-10. https://doi.org/10.1111/jch.13089
